{"schema_version":"secwatch.filing_event.v1","accession":"0001698530-24-000110","form_type":"8-K","ticker":"XCUR","cik":"0001698530","company_name":"EXICURE, INC.","filed_at":"2024-09-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.154752+00:00","generated_at":"2026-05-31T00:46:25.035688+00:00","sec_items":["1.01","2.01","5.02","9.01"],"event_type":"m_and_a","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Exicure sells core SNA technology to Flashpoint for $1.5M; appoints new director","bullets":["Sold spherical nucleic acid technology, R&D programs, and clinical assets to Flashpoint Therapeutics for $1.5 million gross proceeds.","Will receive royalties on future licensing or sublicensing of the assets by Flashpoint.","Board increased to seven; Eui Yull Hwang appointed as independent Class II director.","No material relationship exists between Exicure and Flashpoint aside from the transaction."],"urls":{"canonical":"https://secwatch.observer/filing/0001698530-24-000110","json":"https://secwatch.observer/filing/0001698530-24-000110.json","markdown":"https://secwatch.observer/filing/0001698530-24-000110.md","text":"https://secwatch.observer/filing/0001698530-24-000110.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1698530/000169853024000110/0001698530-24-000110-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1698530/000169853024000110/xcur-20240930.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T00:46:25.035688+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1d4c5b7759","claim":"Eui Yull Hwang was appointed as Independent Director at EXICURE, INC..","evidence_excerpt":"On September 26, 2024, the Board increased the size of the Board from six directors to seven directors and appointed Eui Yull Hwang as an independent director to fill the vacancy.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1698530/000169853024000110/0001698530-24-000110-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Independent Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}